Home > Financial Ratios > THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES
Core EBITDA Margin

    Back to All Ratios
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for THYROCARE TECHNOLOGIES
Please provide your vote to see the results

THYROCARE TECHNOLOGIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 23.2740.0334.6239.9738.26

What is the latest Core EBITDA Margin ratio of THYROCARE TECHNOLOGIES ?

The latest Core EBITDA Margin ratio of THYROCARE TECHNOLOGIES is 23.27 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar202323.27
Mar202240.03
Mar202134.62
Mar202039.97
Mar201938.26

How is Core EBITDA Margin of THYROCARE TECHNOLOGIES Trending?

Years Core EBITDA Margin % Change
Mar2023 23.27
-41.87
Mar2022 40.03
15.63
Mar2021 34.62
-13.39
Mar2020 39.97
4.47
Mar2019 38.26 -

Other Financial Ratios of THYROCARE TECHNOLOGIES


Compare Core EBITDA Margin ratio of peers of THYROCARE TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES ₹3,440.0 Cr -0.7% 4.4% 40.8% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹85,581.4 Cr 1.7% -1.8% 30.8% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹81,699.0 Cr 3.7% 9% 65.8% Stock Analytics
GLOBAL HEALTH ₹38,124.0 Cr -0.6% 2.5% 147.8% Stock Analytics
FORTIS HEALTHCARE ₹34,041.1 Cr 1.7% 3.8% 63.8% Stock Analytics
NARAYANA HRUDAYALAYA ₹26,421.8 Cr 3.5% 4.2% 71.1% Stock Analytics


THYROCARE TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES

-0.7%

4.4%

40.8%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses